The rapid attainment of this key new Quality Management Standard confirms Cherwell’scommitment to developing and improving its own quality processes to maintain full compliance within the regulatory world.
In order to meet the stringent quality demands of the pharmaceutical industry, every batch of media shipped by Cherwell is individually certificated in line with Pharmacopoeia requirements. Growth promotion and fertility tests undertaken within Cherwell’s own quality assurance laboratories validate the performance of every batch of media via a detailed Quality Control certificate. This confirms that specific media products will enable the growth of the correct microorganisms for that particular media formulation.
Cherwell has also recently undergone a number of successful quality assurance audits by some of its major pharmaceutical customers which require that Cherwell’s own standards measure up to the GMP (Good Manufacturing Practice) standards that are required of the pharmaceutical companies themselves by the MHRA (Medicines and Healthcare products Regulatory Agency).
Andy Whittard, Managing Director at Cherwell Laboratories said: “We are extremely pleased to be able to so successfully demonstrate the quality of our products, facilities and customer service. The Redipor brand has certainly built a strong reputation within the pharmaceutical industry for high quality products and a flexible, efficient service. Indeed, all our products are manufactured under the control of the ISO9001:2008 registered Quality Management system. At the core of this system is a desire to continually improve the quality of products and service offered. This can definitely be demonstrated by the high degree of positive feedback from our recent customer satisfaction survey.”
